Search
Bicycle Therapeutics PLC
BCYCAdd to Watchlist
3.610USD
+0.130+3.74%
Close 11-06 16:00（ET）
252.02MMarket Cap
LossP/E TTM
Today
+3.74%
5 Days
-1.37%
1 Month
-4.75%
6 Months
-29.90%
Year to Date
-49.01%
1 Year
-44.55%
Key Figures
3.500Open
3.685High
17.43KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.03%Turnover Ratio
3.480Prev. Close
3.490Low
62.87KTurnover
LossP/E Static
0.50P/B
0.00%Div Yield TTM
-28.51%ROA
7.83052wk High
0.06Volume Ratio
-169.03MNet Profit
69.81MShares
-3.1554EPS TTM
1.55Beta
-33.84%ROE
3.33052wk Low
6.47%Amplitude
100.00%Gross Margin
252.02MMarket Cap
-2.07Reward/Risk
3.19%Risk Rate
Bicycle Therapeutics PLC's Score
0.04vs previous score
Forecast8.00
Financial Health8.10
Technical3.95
Valuation Dimensions7.56
Institutional Confidence5.00
Risk Assessment4.07
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Bicycle Therapeutics PLC Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.15/-0.43
Revenue / Forecast
34.06M/6.07M
Bicycle Therapeutics PLC Profile
SectorBiotechnology & Medical Research
Ticker SymbolBCYC
Number of employees305
CountryUnited Kingdom
Ownership
| Shareholders | Proportion |
|---|---|
| Baker Bros. Advisors LP | 21.68% |
| Forbion Capital Partners | 6.89% |
| Armistice Capital LLC | 6.42% |
| Acadian Asset Management LLC | 3.32% |
| Shareholder Types | Proportion |
|---|---|
| Hedge Fund | 36.92% |
| Investment Advisor | 14.08% |
| Investment Advisor/Hedge Fund | 7.12% |
| Venture Capital | 7.12% |
Related Instruments
-0.79%
+1.43%
+1.07%
-0.14%
+0.38%
-0.22%
+0.03%
-0.41%
+0.02%
-0.20%
+0.85%
-1.57%
-1.04%
+0.28%
+5.27%
-0.16%
+0.16%
-0.80%
+1.46%
+3.63%Popular Instruments
51290.600
-208.500 (-0.41%)
26964.500
+329.300 (+1.24%)
7380.000
+23.100 (+0.31%)
12797.000
-1.000 (-0.01%)
58142.000
+876.000 (+1.53%)
6140.600
-37.200 (-0.60%)
89.857
-0.176 (-0.20%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4065.670
-33.020 (-0.81%)
FAQs
What is the current price of Bicycle Therapeutics PLC (BCYC)?
The current price of Bicycle Therapeutics PLC (BCYC) is 3.61.
What is the symbol of Bicycle Therapeutics PLC?
The ticker symbol of Bicycle Therapeutics PLC is BCYC.
What is the 52-week high of Bicycle Therapeutics PLC?
The 52-week high of Bicycle Therapeutics PLC is 7.83.
What is the 52-week low of Bicycle Therapeutics PLC?
The 52-week low of Bicycle Therapeutics PLC is 3.33.
What is the market capitalization of Bicycle Therapeutics PLC?
The market capitalization of Bicycle Therapeutics PLC is 252.02M.
Is Bicycle Therapeutics PLC (BCYC) currently rated as Buy, Hold, or Sell?
According to analysts, Bicycle Therapeutics PLC (BCYC) has an overall rating of Buy, with a price target of 9.86.
What is the Earnings Per Share (EPS TTM) of Bicycle Therapeutics PLC (BCYC)?
The Earnings Per Share (EPS TTM) of Bicycle Therapeutics PLC (BCYC) is -3.16.